Allogeneic, syngeneic, and autologous bone marrow transplantation in the acute leukemias--Baltimore experience.

G. W. Santos, Andrew M Yeager, R. Saral

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In presentation of our data in context of other clinical series, we have identified a few bone marrow transplant preparative regimens that appear to have a superior advantage over others as far as their antileukemic effects are concerned. So far, the delayed and late effects of the treatment appear to be quite acceptable considering the ultimate fatal outcome in the acute leukemias, in particular those in their second remission. GvHD and viral infections account for about two-thirds of the mortalities in series where leukemic relapse is very low. It is hoped that solutions or at least partial solutions will not only improve the overall therapeutic results, but will allow us to extend the procedure to older patients. It is suggested that the need for unrelated HLA "matched" donors may be supplanted by the use of autologous bone marrow transplants, particularly in the older patients.

Original languageEnglish (US)
Pages (from-to)226-232
Number of pages7
JournalHamatologie und Bluttransfusion
Volume30
StatePublished - Jan 1 1987
Externally publishedYes

Fingerprint

Baltimore
Autologous Transplantation
Bone Marrow Transplantation
Leukemia
Bone Marrow
Transplants
Fatal Outcome
Virus Diseases
Tissue Donors
Recurrence
Mortality
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Allogeneic, syngeneic, and autologous bone marrow transplantation in the acute leukemias--Baltimore experience. / Santos, G. W.; Yeager, Andrew M; Saral, R.

In: Hamatologie und Bluttransfusion, Vol. 30, 01.01.1987, p. 226-232.

Research output: Contribution to journalArticle

@article{f78c189cdfff45019f227fe071fbc854,
title = "Allogeneic, syngeneic, and autologous bone marrow transplantation in the acute leukemias--Baltimore experience.",
abstract = "In presentation of our data in context of other clinical series, we have identified a few bone marrow transplant preparative regimens that appear to have a superior advantage over others as far as their antileukemic effects are concerned. So far, the delayed and late effects of the treatment appear to be quite acceptable considering the ultimate fatal outcome in the acute leukemias, in particular those in their second remission. GvHD and viral infections account for about two-thirds of the mortalities in series where leukemic relapse is very low. It is hoped that solutions or at least partial solutions will not only improve the overall therapeutic results, but will allow us to extend the procedure to older patients. It is suggested that the need for unrelated HLA {"}matched{"} donors may be supplanted by the use of autologous bone marrow transplants, particularly in the older patients.",
author = "Santos, {G. W.} and Yeager, {Andrew M} and R. Saral",
year = "1987",
month = "1",
day = "1",
language = "English (US)",
volume = "30",
pages = "226--232",
journal = "Hamatologie und Bluttransfusion",
issn = "0440-0607",

}

TY - JOUR

T1 - Allogeneic, syngeneic, and autologous bone marrow transplantation in the acute leukemias--Baltimore experience.

AU - Santos, G. W.

AU - Yeager, Andrew M

AU - Saral, R.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - In presentation of our data in context of other clinical series, we have identified a few bone marrow transplant preparative regimens that appear to have a superior advantage over others as far as their antileukemic effects are concerned. So far, the delayed and late effects of the treatment appear to be quite acceptable considering the ultimate fatal outcome in the acute leukemias, in particular those in their second remission. GvHD and viral infections account for about two-thirds of the mortalities in series where leukemic relapse is very low. It is hoped that solutions or at least partial solutions will not only improve the overall therapeutic results, but will allow us to extend the procedure to older patients. It is suggested that the need for unrelated HLA "matched" donors may be supplanted by the use of autologous bone marrow transplants, particularly in the older patients.

AB - In presentation of our data in context of other clinical series, we have identified a few bone marrow transplant preparative regimens that appear to have a superior advantage over others as far as their antileukemic effects are concerned. So far, the delayed and late effects of the treatment appear to be quite acceptable considering the ultimate fatal outcome in the acute leukemias, in particular those in their second remission. GvHD and viral infections account for about two-thirds of the mortalities in series where leukemic relapse is very low. It is hoped that solutions or at least partial solutions will not only improve the overall therapeutic results, but will allow us to extend the procedure to older patients. It is suggested that the need for unrelated HLA "matched" donors may be supplanted by the use of autologous bone marrow transplants, particularly in the older patients.

UR - http://www.scopus.com/inward/record.url?scp=0023070093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023070093&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 226

EP - 232

JO - Hamatologie und Bluttransfusion

JF - Hamatologie und Bluttransfusion

SN - 0440-0607

ER -